GBM were formerly designated as either IDH-wildtype or IDH-mutant; however, the latter subtype has since been re-classified by the World Health Organization (WHO) as Grade IV astrocytoma IDH-mutant [2]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).